Improved survival in the Danish center‐treated cystic fibrosis patients: Results of aggressive treatment

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Pediatric Pulmonology

• Publication date

  1996-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/(SICI)1099-0496(199603)21:3<153::AID-PPUL1>3.0.CO;2-RPMID 8860069
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Diabetes mellitus in cystic fibrosis: effect of insulin therapy on lung function and infections

  1994cited by this paper
• Screening for carriers of cystic fibrosis

  1994cited by this paper
• Cystic fibrosis in the United Kingdom, 1968-1988: incidence, population and survival.

  1993cited by this paper
• The changing epidemiology of cystic fibrosis.

  1993cited by this paper
• Screening for Carriers of Cystic Fibrosis among Pregnant Women: A Pilot Study

  1993cited by this paper
• Cystic fibrosis: beyond the gene to therapy.

  1992cited by this paper
• Low incidence of pulmonary Pseudomonas cepacia infection in Danish cystic fibrosis patients

  1992cited by this paper
• Influence of the development of diabetes mellitus on clinical status in patients with cystic fibrosis

  1992cited by this paper
• Prediction of mortality in patients with cystic fibrosis.

  1992cited by this paper
• Prevention of chronic Pseudomonas aeruginosa colonisation in cystic fibrosis by early treatment.

  1991cited by this paper
• Cystic fibrosis: current survival and population estimates to the year 2000.

  1991cited by this paper
• Glucose tolerance in cystic fibrosis.

  1991cited by this paper
• Severity of cystic fibrosis in patients homozygous and heterozygous for ΔF508 mutation

  1991cited by this paper
• Severity of cystic fibrosis in patients homozygous and heterozygous for delta F508 mutation.

  1991cited by this paper
• Frequency of the delta F508 mutation on cystic fibrosis chromosomes in Denmark.

  1990cited by this paper
• Diabetes mellitus in patients with cystic fibrosis: effect on survival.

  1990cited by this paper
• Estimated Risk of Cross‐Infection with Pseudomonas aeruginosa in Danish Cystic Fibrosis Patients

  1989cited by this paper
• A comparison of survival, growth, and pulmonary function in patients with cystic fibrosis in Boston and Toronto.

  1988cited by this paper
• Diabetes mellitus associated with cystic fibrosis.

  1988cited by this paper
• Colistin inhalation therapy in cystic fibrosis patients with chronic Pseudomonas aeruginosa lung infection.

  1987cited by this paper
• The efficacy and safety of ciprofloxacin and ofloxacin in chronic Pseudomonas aeruginosa infection in cystic fibrosis.

  1987cited by this paper
• An epidemic spread of multiresistant Pseudomonas aeruginosa in a cystic fibrosis centre.

  1986cited by this paper
• Frequent antibiotic therapy improves survival of cystic fibrosis patients with chronic Pseudomonas aeruginosa infection.

  1984cited by this paper
• FREQUENT ANTIBIOTIC THERAPY IMPROVES SURVIVAL OF CYSTIC FIBROSIS PATIENTS WITH CHRONIC PSEUDOMONAS AERUGINOSA INFECTION

  1983cited by this paper
• Survival patterns in cystic fibrosis

  1975cited by this paper
• Survival patterns in cyctic fibrosis.

  1975cited by this paper

• Impact of CFTR Modulators on Longitudinal Cystic Fibrosis Survival and Mortality: Review and Secondary Analysis

  2025cites this paper
• Close monitoring and early intervention: management principles for cystic fibrosis in Denmark

  2024cites this paper
• Cystic fibrosis and the clinical biofilm revolution A survey of the Danish CF Center's contribution

  2024cites this paper
• 16S rRNA-Based Microbiota Profiling Assists Conventional Culture Analysis of Airway Samples from Pediatric Cystic Fibrosis Patients

  2023cites this paper
• Antimicrobial Strategies for Cystic Fibrosis

  2022cites this paper
• Evaluation of bone metabolism in children with cystic fibrosis.

  2021cites this paper
• FULL TITLE : Intravenous antibiotic use and exacerbation events in an adult cystic fibrosis centre: a prospective observational study AUTHOR NAMES:

  2020cites this paper
• Scnn1b-Transgenic BALB/c Mice as a Model of Pseudomonas aeruginosa Infections of the Cystic Fibrosis Lung

  2020cites this paper
• Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis.

  2020cites this paper
• Pro Con Debate - Infection prevention and control in cystic fibrosis: One size fits all The argument against.

  2019cites this paper
• Intravenous antibiotic use and exacerbation events in an adult cystic fibrosis centre: A prospective observational study.

  2019cites this paper
• Iron-containing Nanoparticles for the Treatment of Chrionic Biofilm Infections in Cystic Fibrosis

  2019cites this paper
• Sugar-powered nanoantimicrobials for combating bacterial biofilms.

  2019cites this paper
• Microbiology of Upper Respiratory Tract Pathogens in Cystic Fibrosis Patients

  2018cites this paper
• Bronchiectasis and Chronic Suppurative Lung Disease

  2018cites this paper
• Four Decades of β-Lactam Antibiotic Pharmacokinetics in Cystic Fibrosis

  2018cites this paper
• Rhinotillexomania in a Cystic Fibrosis Patient Resulting in Septal Perforation

  2018cites this paper
• Bacterial autoaggregation

  2018cites this paper
• Potential application of phage therapy for prophylactic treatment against Pseudomonas aeruginosa biofilm Infections

  2018cites this paper
• Phenotypic shift in Pseudomonas aeruginosa populations from cystic fibrosis lungs after 2-week antipseudomonal treatment.

  2017cites this paper
• Oxygen therapy for cystic fibrosis (Review)

  2017cites this paper
• Emerging biofilm producing multi-drug resistant mucoid strains of Pseudomonas Aeruginosa in a rural medical college hospital in North Kerala

  2017cites this paper
• Practical use of the multiple breath washout test in children: biological variability in health and disease

  2017cites this paper
• Pros, cons and future of antibiotics

  2017cites this paper
• Four case reports of Chinese cystic fibrosis patients and literature review

  2017cites this paper
• The Role of Bacterial Biofi lms in Chronic Infections

  2017cites this paper
• Relevance of multidrug-resistant Pseudomonas aeruginosa infections in cystic fibrosis.

  2017cites this paper
• Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis.

  2017cites this paper
• Comparing the harmful effects of nontuberculous mycobacteria and Gram negative bacteria on lung function in patients with cystic fibrosis☆

  2016cites this paper
• Topical cystic fibrosis transmembrane conductance regulator gene replacement for cystic fibrosis-related lung disease.

  2016cites this paper
• Topical cystic fibrosis transmembrane conductance regulator gene replacement for cystic fibrosis-related lung disease.

  2016cites this paper
• Home intravenous antibiotic therapy in children with cystic fibrosis: clinical outcome, quality of life and economic benefit.

  2016cites this paper
• The impact of a national population carrier screening program on cystic fibrosis birth rate and age at diagnosis: Implications for newborn screening.

  2016cites this paper
• Microbial biofilms: impact on the pathogenesis of periodontitis, cystic fibrosis, chronic wounds and medical device-related infections.

  2015cites this paper
• Cost-effectiveness of newborn screening for cystic fibrosis determined with real-life data.

  2015cites this paper
• Evidence for the efficacy of aztreonam for inhalation solution in the management of Pseudomonas aeruginosa in patients with cystic fibrosis

  2015cites this paper
• Clinical Updates in Cystic Fibrosis–Related Diabetes

  2015cites this paper
• Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis.

  2015cites this paper
• Open label study of inhaled aztreonam for Pseudomonas eradication in children with cystic fibrosis: The ALPINE study.

  2015cites this paper
• UNIVERSIDADE DE LISBOA

  2015cites this paper
• Cystic Fibrosis Foundation pulmonary guideline. pharmacologic approaches to prevention and eradication of initial Pseudomonas aeruginosa infection.

  2014cites this paper
• Enhanced In Vitro Formation and Antibiotic Resistance of Nonattached Pseudomonas aeruginosa Aggregates through Incorporation of Neutrophil Products

  2014cites this paper
• Differences in clinical condition and genotype at time of diagnosis of cystic fibrosis by newborn screening or by symptoms.

  2014cites this paper
• Expression of antisense small RNAs in response to stress in Pseudomonas aeruginosa

  2014cites this paper
• Pulmonary disease in cystic fibrosis: assessment with chest CT at chest radiography dose levels.

  2014cites this paper
• The role of bacterial biofilms in chronic infections

  2013cites this paper
• Decision Making about Risk of Infection by Young Adults with CF

  2013cites this paper
• Eight-weekly intravenous antibiotics is beneficial in severe bronchiectasis.

  2013cites this paper
• The effect of socio-economic status on outcomes in cystic fibrosis

  2013cites this paper
• Genome-wide identification of novel small RNAs in Pseudomonas aeruginosa

  2013cites this paper
• Oxygen therapy for cystic fibrosis.

  2013cites this paper
• Thought-provoking Molecules for Drug Discovery: antioxidants

  2013cites this paper
• Topical cystic fibrosis transmembrane conductance regulator gene replacement for cystic fibrosis-related lung disease.

  2013cites this paper
• Elective versus symptomatic intravenous antibiotic therapy for cystic fibrosis.

  2012cites this paper
• Understanding the natural progression in %FEV1 decline in patients with cystic fibrosis: a longitudinal study

  2012cites this paper
• Topical cystic fibrosis transmembrane conductance regulator gene replacement for cystic fibrosis-related lung disease.

  2012cites this paper
• A guide for primary care

  2012cites this paper
• Current dilemmas in antimicrobial therapy in cystic fibrosis

  2012cites this paper
• Bronchiectasis - a guide for primary care.

  2012cites this paper
• Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis.

  2012cites this paper
• Inhaled Therapy in Children

  2012cites this paper
• Cystic fibrosis

  2012cites this paper
• Managing cystic fibrosis: strategies that increase life expectancy and improve quality of life.

  2011cites this paper
• Antibiotic treatment strategies in adults with bronchiectasis

  2011cites this paper
• New developments in aminoglycoside therapy and ototoxicity.

  2011cites this paper
• Stenotrophomonas maltophilia in cystic fibrosis: guilty or innocent?

  2011cites this paper
• PmrB mutations promote polymyxin resistance of Pseudomonas

  2011cites this paper
• The implementation of standards of care in Europe: state of the art.

  2011cites this paper
• Association between socioeconomic status, sex, and age at death from cystic fibrosis in England and Wales (1959 to 2008): cross sectional study

  2011cites this paper
• Age at diagnosis and disease progression of cystic fibrosis in an area without newborn screening.

  2011cites this paper
• The clinical impact of bacterial biofilms

  2011cites this paper
• Pseudomonas aeruginosa Biofilms in the Lungs of Cystic Fibrosis Patients

  2011cites this paper
• Self Determination and Health Behaviors in Children with Cystic Fibrosis

  2011cites this paper
• Biofilm production using distinct media and antimicrobial susceptibility profile of Pseudomonas aeruginosa.

  2011cites this paper
• Benchmarking improves quality in cystic fibrosis care: a pilot project involving 12 centres.

  2011cites this paper
• Chronic Pseudomonas aeruginosa infection definition: EuroCareCF Working Group report.

  2011cites this paper
• Validation and use of a parametric model for projecting cystic fibrosis survivorship beyond observed data: a birth cohort analysis

  2011cites this paper
• PmrB Mutations Promote Polymyxin Resistance of Pseudomonas aeruginosa Isolated from Colistin-Treated Cystic Fibrosis Patients

  2011cites this paper
• Side effects of aminoglycosides on the kidney, ear and balance in cystic fibrosis

  2010cites this paper
• The Clinical Utility of Molecular Typing of Multiply-resistant Pseudomonas aeruginosa in Children with Cystic Fibrosis

  2010cites this paper
• Minimizing the toxicity of aminoglycosides in cystic fibrosis

  2010cites this paper
• Reproductive and contraceptive issues in chronically ill adolescents

  2010cites this paper
• Efficacy of the Combination of Tobramycin and a Macrolide in an InVitroPseudomonas aeruginosa Mature Biofilm Model

  2010cites this paper
• Analysis of the Bacterial Communities Present in Lungs of Patients with Cystic Fibrosis from American and British Centers

  2010cites this paper
• Lung function in patients with primary ciliary dyskinesia: a cross-sectional and 3-decade longitudinal study.

  2010cites this paper
• Antibiotic resistance of bacterial biofilms.

  2010cites this paper
• Development of low-dose protocols for thin-section CT assessment of cystic fibrosis in pediatric patients.

  2010cites this paper
• Population Pharmacokinetic Comparison and Pharmacodynamic Breakpoints of Ceftazidime in Cystic Fibrosis Patients and Healthy Volunteers

  2010cites this paper
• An exploration of the factors involved in lifestyle decisions in young people with cystic fibrosis using decision making vignettes, and the role of perceived risk in infection

  2010cites this paper
• Implications of Biofilm Formation in Chronic Wounds and in Cystic Fibrosis

  2010cites this paper
• Side effects of aminoglycosides on the kidney , ear and balance in cystic fibrosis

  2010cites this paper
• Treatment strategies for cystic fibrosis: what's in the pipeline?

  2009cites this paper
• Terminale Lungeninsuffizienz bei milder Mukoviszidose?

  2009cites this paper
• Respiratory exacerbations

  2009cites this paper
• Terminale Lungeninsuffizienz bei milder Mukoviszidose? Fallbericht und Plädoyer für die Notwendigkeit einer Betreuung im spezi alisierten CF-Zentrum Terminal Pulmonary Insufficiency Due to Mild Cystic Fibrosis? Case Report and Plea for the Necessity to Care for CF-Patients in Specialised Centres

  2009cites this paper
• Concordant genotype of upper and lower airways P aeruginosa and S aureus isolates in cystic fibrosis

  2009cites this paper
• Treatmentstrategiesforcystic fibrosis:what'sinthepipeline?

  2009cites this paper
• Intravenous antibiotics and Pseudomonas aeruginosa

  2009cites this paper
• Real life evaluation of intravenous antibiotic treatment in a paediatric cystic fibrosis centre: outcome of home therapy is not inferior.

  2009cites this paper
• Eradication of early Pseudomonas infection in cystic fibrosis

  2009cites this paper